BioHealth and Life Sciences Update - 9/14/16
Pii to Receive $93M in Growth Capital to Expand Operations and Pipeline
Hunt Valley's Pii, a contract development and manufacturing organization, agrees to receive $93M in growth capital from an investor consortium to expand Pii's formulation capabilities, commercial manufacturing operations, and pipeline of generic products.
BioHealth and Life Sciences News
Germantown's Neuralstem receives $20M strategic investment from Tianjin Pharmaceutical Group to support clinical research and development. 

Columbia's Well Doc agrees to finalize a commercial partnership with LifeScan Inc., a Johnson & Johnson diabetes care company to deliver combined, Best-in-Class digital therapeutic solution for patients with Type 2 Diabetes.

Frederick's Rooster BIO and the US Army Institute of Surgical Research (USAISR) sign a CRADA to accelerate the development of Regenerative Medicine.

Rockville's Supernus receives FDA tentative approval for an expanded label of Trokendi XR® to include Migraine prophylaxis in adults.

Gaithersburg's MaxCyte bolster's its distributor network in Asia to meet growing market demands for MaxCyte STX® and MaxCyte VLX® transfection systems.

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announces a $14.4 million grant from NIAID for HIV vaccine research.

Baltimore's Lupin Pharmaceuticals receives FDA approval for potassium chloride extended-release capsules and for generic Klor-Con® Extended-Release Tablets.

Rockville's U.S. Pharmacopeial Convention (USP) launches a new food fraud database to help industry and regulators mitigate the risk of food adulteration.

Rockville's RegenXBio announces positive data from ongoing preclinical studies of NAV® gene therapy in neurodegenerative diseases.

NIH announces $20M Antimicrobial Resistance Diagnostic Challenge to encourage development of new, innovative and novel laboratory diagnostic tests.

NIH's National Center for Advancing Translational Sciences (NCATS) is making progress in potentially treating Zika infections with repurposed drugs. 

NIH's National Cancer Institute (NCI) announces ten "Cancer Moonshot" recommendations designed to improve outcomes for cancer patients. 

BIO International is seeking proposals for speakers and sessions for next June's conference in San Diego. (Deadline to apply is October 13th.)

Seeking lab space?  Contact Maryland Department of Commerce for options. 
Upcoming Deadlines and Events
9/15 - Women in BIO meetup (Baltimore)
9/30 - Developing a Business Plan (Frederick)
9/30 - 10/1 - Korea - US Cooperative Conference for Life Science (Germantown)
10/3 - Deadline to Apply for TEDCO TCF/CIF
10/5 - Avoiding 10 Most Common Mistakes Made by Healthcare Entrep (Rockville)
10/6 - Perfecting Your Pitch - CEO Roundtable (Baltimore)
10/14 - Deadline to Apply for MIPS Technology Product Development Awards
10/17-10/19 - AdvaMed 2016 (Minneapolis)
10/31 - Deadline to Apply for VOLT Fund Tech Loans
11/14 - Entrepreneur Expo (Baltimore)
Look Who's Hiring 
     
     Acell (Columbia) 
                                                                                                To view more job opportunities,
     Macrogenics (Rockville)
                                                                                               please check at the bottom of the 
     NexImmune (Gaithersburg)  
                                                                                                         MD COMMERCE 
     Paragon Biosciences (Baltimore)  
                                                                                            BioHealth and Life Sciences website.
     Pharmaceutics International - Pii (Hunt Valley) 
                                                                     
                                                                            
Spotlight:  Maryland BioHealth Innovators
   
Frederick's KempBio specializes in monoclonal antibody production and protein services such as baculovirus, PEI-mediated transient mammalian and more.
The Maryland Department of Commerce focuses on attracting, retaining, and expanding businesses and creating jobs in Maryland, and also markets Maryland's many assets to companies across the nation and abroad.  

The Department's Office of BioHealth and Life Sciences s
upports innovative start-ups and companies focused on animal and human health, health IT, research tools, and related technologies.  These include those involving agricultural and marine bio, biodefense, therapeutics, vaccines, diagnostics, medical devices, biologics, nutraceuticals, personalized and regenerative medicine, digital health, mHealth, telemedicine, EHR, bioinformatics, data center services, patient engagement, and wellness.
Maryland Department of Commerce
 
Office of BioHealth and Life Sciences 
401 East Pratt Street
7th Floor  |  Baltimore, MD 21202
410.767.0505

9600 Gudelsky Drive
Rockville, MD 20850
240.314.6171

BioHealth.Info@Maryland.gov

Click here for BLS newsletter archives


Like us on Facebook Follow us on Twitter View our photos on flickr View our videos on YouTube View our profile on LinkedIn